These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17308116)

  • 21. CD82, and CD63 in thyroid cancer.
    Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C
    Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs).
    Ishii H; Yazawa T; Sato H; Suzuki T; Ikeda M; Hayashi Y; Takanashi Y; Kitamura H
    Lung Cancer; 2004 Sep; 45(3):325-37. PubMed ID: 15301873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
    Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW
    Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models.
    Yang JM; Peng ZH; Si SH; Liu WW; Luo YH; Ye ZY
    Liver Int; 2008 Jan; 28(1):132-9. PubMed ID: 18028322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
    Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S
    Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
    Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
    Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
    Jee BK; Park KM; Surendran S; Lee WK; Han CW; Kim YS; Lim Y
    Biochem Biophys Res Commun; 2006 Apr; 342(2):655-61. PubMed ID: 16488391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.
    Lin J; Lalani AS; Harding TC; Gonzalez M; Wu WW; Luan B; Tu GH; Koprivnikar K; VanRoey MJ; He Y; Alitalo K; Jooss K
    Cancer Res; 2005 Aug; 65(15):6901-9. PubMed ID: 16061674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder.
    Ai X; Zhang X; Wu Z; Ma X; Ju Z; Wang B; Shi T
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):79-82. PubMed ID: 17393117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of KAI1, MRP-1, and FAK proteins in lung cancer detected by high-density tissue microarray].
    Wang XY; Liu T; Zhu CZ; Li Y; Sun R; Sun CY; Wang AX
    Ai Zheng; 2005 Sep; 24(9):1091-5. PubMed ID: 16159431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells.
    Yang X; Wei LL; Tang C; Slack R; Mueller S; Lippman ME
    Cancer Res; 2001 Jul; 61(13):5284-8. PubMed ID: 11431371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro.
    Koizumi K; Kozawa Y; Ohashi Y; Nakamura ES; Aozuka Y; Sakurai H; Ichiki K; Doki Y; Misaki T; Saiki I
    Oncol Rep; 2007 Jun; 17(6):1511-6. PubMed ID: 17487412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between the levels of KAI1/CD82 and CD44 and the clinicopathological features of non-small cell lung cancer].
    Chen QY; Lin XM; Zhou JY; An Z; Yang L; Jiang ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):101-4. PubMed ID: 14990184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRP-1/CD9 gene transduction downregulates Wnt signal pathways.
    Huang CL; Liu D; Masuya D; Kameyama K; Nakashima T; Yokomise H; Ueno M; Miyake M
    Oncogene; 2004 Sep; 23(45):7475-83. PubMed ID: 15334057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer.
    Sho M; Adachi M; Taki T; Hashida H; Konishi T; Huang CL; Ikeda N; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M
    Int J Cancer; 1998 Oct; 79(5):509-16. PubMed ID: 9761121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transduction of KAI1/CD82 cDNA promotes hematogenous spread of human lung-cancer cells in natural killer cell-depleted SCID mice.
    Shinohara T; Nishimura N; Hanibuchi M; Nokihara H; Miki T; Hamada H; Sone S
    Int J Cancer; 2001 Oct; 94(1):16-23. PubMed ID: 11668473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese.
    Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H
    Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
    Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M
    Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues.
    Huang C; Taki T; Adachi M; Yagita M; Sawada S; Takabayashi A; Inufusa H; Yoshie O; Miyake M
    Int J Oncol; 1997 Nov; 11(5):1045-51. PubMed ID: 21528303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.